Supernus Pharmaceuticals
SUPN
#3900
Rank
A$4.40 B
Marketcap
A$76.60
Share price
-0.74%
Change (1 day)
52.43%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: A$4.40 Billion

As of March 2026 Supernus Pharmaceuticals has a market cap of A$4.40 Billion. This makes Supernus Pharmaceuticals the world's 3900th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$4.40 B-0.31%
2025A$4.41 B33.75%
2024A$3.30 B42.23%
2023A$2.32 B-18.1%
2022A$2.83 B32.47%
2021A$2.13 B23.65%
2020A$1.72 B-2.8%
2019A$1.77 B-27.86%
2018A$2.46 B-5.72%
2017A$2.61 B50.79%
2016A$1.73 B91.94%
2015A$0.90 B107.44%
2014A$0.43 B28.95%
2013A$0.33 B59.97%
2012A$0.21 B

End of Day market cap according to different sources

On Mar 6th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

A$4.40 Billion
by Nasdaq info icon info icon
A$4.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$823.76 B 18,617.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$270.70 B 6,050.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.260 T 28,536.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$174.57 B 3,866.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
A$2.13 B-51.53%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$29.79 B 577.06%๐Ÿ‡บ๐Ÿ‡ธ USA